A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MA-0211 in Healthy Adult Subjects Including a Food Effect Cohort
Clinical trial NCT03682484 · COMPLETED
Trial details
- NCT number
- NCT03682484
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-29
- Primary completion
- 2018-03-26
- Enrollment
- 320
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.